3. December 2018 - 2018 Developing

investor news

MPH Health Care AG: Investments developing positive

  •  CR Capital Real Estate raises sales and profit forecast
  • Haemato increases earnings by approx. 50% in the first 9 months
  • M1 Kliniken opens further locations

Berlin, 03 December 2018: The affiliated companies of MPH Health Care AG (ISIN: DE000A0L1H32) have confirmed their growth course with positive news.

CR Capital Real Estate AG has significantly increased its sales and profit forecast for the current year 2018. The real estate company focuses on the creation of affordable living space in the metropolises of Berlin and Leipzig and their environs. Group sales in 2018 are expected to increase from EUR 10.4 million in the previous year to over EUR 20 million. The annual surplus is to rise from 5.8 million euros to over 7 million euros. The project in Schkeuditz with 96 terraced houses is decisive for the positive development. In addition, plots close to Berlin were acquired. Here, too, semi-detached and terraced houses are expected to be built.

HAEMATO AG reported on the development in the first nine months of 2018. The provider of special pharmaceuticals increased its profit by 50.5 percent from EUR 3.9 million to EUR 5.87 million compared to the same period of the previous year. Sales increased slightly from EUR 211.3 million to EUR 212.8 million. HAEMATO specializes in drugs for the treatment of chronic diseases and sees further growth potential. In addition, the operating margin is to be increased sustainably. Therefor, the Executive Board is working on optimizing business processes through digitization.

M1 Kliniken AG, the number 1 in the field of beauty medicine in Germany, continues its expansion course in 2018. 4 new specialist centres have been opened so far this year. Two more are to follow by the end of the year. The M1 Group will thus operate a total of 24 specialist centres for aesthetic treatments by the end of 2018. The increase of more than 30% compared to the previous year is in line with corporate planning. M1 Kliniken AG is thus creating an important condition for a further significant increase in sales in the coming year.